Research note: Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients

Corrine Munoz-Plaza, Shiela M. Strauss, Nelson Tiburcio, Janetta M. Astone-Twerell, Don C. Des Jarlais, Marya Gwadz, Holly Hagan, Andrew Osborne, Andrew Rosenblum

Research output: Contribution to journalArticle

Abstract

Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the discrepancy in funding for services to address these two diseases has implications. Although drug treatment programs have played an important role in fighting HIV/AIDS, the HCV-related services offered at these programs remain limited. Research from other countries suggests that drug users view HCV as less important than HIV, yet little is known about the extent to which our society's focus on HIV has been adopted within the drug treatment program culture. This qualitative study examines the perceptions of both staff (n = 165) and clients (n = 215) at these programs with regard to HIV and HCV and presents data on how staffs' attitudes toward HCV changed after participating in an HCV training. Clients described a services landscape at drug treatment programs that favors HIV services over those targeting HCV.

Original languageEnglish (US)
Pages (from-to)517-536
Number of pages20
JournalJournal of Drug Issues
Volume40
Issue number2
DOIs
StatePublished - 2010

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Research note: Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients'. Together they form a unique fingerprint.

  • Cite this